Mochida Pharmaceutical Co., Ltd.

Everything filed on one company: the documents, the statements, the register, the board, the buyback and the property table — each figure as filed, with the report it came from.

Latest values as text and table

Mochida Pharmaceutical Co., Ltd.

Mochida Pharmaceutical Co., Ltd. (持田製薬株式会社, 4534), Pharmaceutical. 12 cross-shareholdings, a board of 16 and 10 largest shareholders, as filed on EDINET for the year to March 2026. EDINET filing S100YI28, filed 2026-06-24. Source: company filings on EDINET (Financial Services Agency of Japan).

Financial summary

Five-year summary as filed, latest filing per fiscal year
Fiscal year endRevenue (¥bn)Profit (¥bn)Total assets (¥bn)EPS (¥)DPS (¥)Employees
2022-03-31110.210.6163.1277.3990.001,544
2023-03-31103.36.6158.8178.9380.001,529
2024-03-31102.94.5158.8126.8080.001,522
2025-03-31105.25.7160.1160.3680.001,508
2026-03-31117.07.9182.7222.9680.001,479

Source: company filings on EDINET (Financial Services Agency of Japan). · JSON

Cross-shareholdings

Ten largest cross-shareholdings by book value, latest annual report
Company heldSharesBook value (¥bn)% of shares outstanding
Nissui Corporation8,000,00010.72.6
Sumitomo Pharma Co., Ltd.913,0001.90.2
Alfresa Holdings Corporation707,6001.80.4
Mitsubishi UFJ Financial Group, Inc.611,0001.60.0
JCR Pharmaceuticals Co.,Ltd.2,200,0001.21.8
TOHO HOLDINGS CO.,LTD.243,4001.20.4
SUZUKEN CO.,LTD.172,9201.00.3
MEDIPAL HOLDINGS CORPORATION319,1000.90.2
Mizuho Financial Group, Inc.50,4080.30.0
HOKUYAKU TAKEYAMA Holdings,Inc.251,5000.21.2

% of shares outstanding: shares held ÷ (issuer's issued shares − treasury shares) × 100, both as filed, the denominator taken from the issuer's own annual securities report nearest the holding's fiscal year end

Source: company filings on EDINET (Financial Services Agency of Japan). · JSON · Markdown